LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 39.41 | 27.76 | 2917 | 3105 | 0.9393 | 0.9817 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 39.41 | 27.76 | 236 | 3105 | 0.0760 | 0.3696 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 39.41 | 27.76 | 3302 | 3105 | 1.0632 | 1.0181 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 41.11 | 27.76 | 198 | 3331 | 0.0594 | 0.3290 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 41.11 | 27.76 | 3149 | 3331 | 0.9452 | 0.9838 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 41.11 | 27.76 | 250 | 3331 | 0.0750 | 0.3747 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 41.11 | 27.76 | 3588 | 3331 | 1.0770 | 1.0216 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 42.81 | 27.76 | 233 | 3596 | 0.0648 | 0.3542 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 42.81 | 27.76 | 3445 | 3596 | 0.9579 | 0.9878 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 42.81 | 27.76 | 335 | 3596 | 0.0932 | 0.4261 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 42.81 | 27.76 | 3903 | 3596 | 1.0853 | 1.0235 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 44.52 | 27.76 | 252 | 3884 | 0.0649 | 0.3627 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 44.52 | 27.76 | 3710 | 3884 | 0.9551 | 0.9872 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 44.52 | 27.76 | 359 | 3884 | 0.0924 | 0.4320 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 44.52 | 27.76 | 4208 | 3884 | 1.0833 | 1.0226 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 46.22 | 27.76 | 305 | 4125 | 0.0739 | 0.3940 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 46.22 | 27.76 | 4031 | 4125 | 0.9772 | 0.9936 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 46.22 | 27.76 | 421 | 4125 | 0.1021 | 0.4577 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 46.22 | 27.76 | 4582 | 4125 | 1.1108 | 1.0293 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 47.93 | 27.76 | 314 | 4421 | 0.0710 | 0.3932 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 47.93 | 27.76 | 4298 | 4421 | 0.9721 | 0.9923 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 47.93 | 27.76 | 465 | 4421 | 0.1052 | 0.4700 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 47.93 | 27.76 | 4957 | 4421 | 1.1211 | 1.0315 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 49.63 | 27.76 | 300 | 4818 | 0.0623 | 0.3771 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 49.63 | 27.76 | 4537 | 4818 | 0.9417 | 0.9839 | MN20160318_Q01 | E21 |